At the end of October, the Brazilian Ministry of Health signed a term of commitment with the University of Oxford, UK, to establish a clinical research and development center in Rio de Janeiro for the British institution’s drugs and vaccines. The plan is for the center, Oxford’s first in the Americas, to begin operation by 2022, to be managed by Brazilian pediatrician Sue Ann Clemens, who coordinated Brazil’s clinical trials of the vaccine jointly produced by the university and AstraZeneca. Clemens currently directs the Institute of Global Health (IFGH) at the University of Siena in Italy. The center to be opened in Rio will receive funding from the British government and scientific support from the IFGH and the International Vaccine Institute in South Korea. The final agreement is expected to be signed in Brazil later this year.
Republish
Print issue
Current | Past
